Ausgabe 5/2021
Inhalt (32 Artikel)
COVID-19 pandemic and transfusion medicine: the worldwide challenge and its implications
Layal Al Mahmasani, Mohammad Hassan Hodroj, Antoine Finianos, Ali Taher
Association between ABO blood types and coronavirus disease 2019 (COVID-19), genetic associations, and underlying molecular mechanisms: a literature review of 23 studies
Yujia Zhang, Rachael Garner, Sana Salehi, Marianna La Rocca, Dominique Duncan
Opioids are not a major cause of death of patients with sickle cell disease
Samir K. Ballas
Prospective cardiac magnetic resonance imaging survey in myelodysplastic syndrome patients: insights from an Italian network
Alessia Pepe, Michele Rizzo, Sara Galimberti, Claudia Baratè, Esther Natalie Oliva, Francesco Arcioni, Sergio Storti, Stefania Renne, Massimo Midiri, Gennaro Restaino, Vincenzo Positano, Maurizio Mangione, Antonella Meloni
Flow cytometric analysis of peripheral blood neutrophil myeloperoxidase expression for ruling out myelodysplastic syndromes: a prospective validation study
Tatiana Raskovalova, Marie-Christine Jacob, Claude-Eric Bulabois, Clara Mariette, Laura Scheffen, Sophie Park, José Labarère
Acute kidney injury adversely affects the clinical course of acute myeloid leukemia patients undergoing induction chemotherapy
Olivier Ballo, Fagr Eladly, Stefan Büttner, Jan Alexander Stratmann, Sarah Rudolf, Uta Brunnberg, Eva-Maria Kreisel, Björn Steffen, Sebastian Wagner, Fabian Finkelmeier, Hubert Serve, Christian H. Brandts
Effects of lenalidomide on the bone marrow microenvironment in acute myeloid leukemia: Translational analysis of the HOVON103 AML/SAKK30/10 Swiss trial cohort
Magdalena M. Brune, Georg Stüssi, Pontus Lundberg, Visar Vela, Dominik Heim, Markus G. Manz, Eugenia Haralambieva, Thomas Pabst, Yara Banz, Mario Bargetzi, Rainer Grobholz, Martin Fehr, Sergio Cogliatti, Gert J. Ossenkoppele, Bob Löwenberg, Christina Biaggi Rudolf, Qiyu Li, Jakob Passweg, Luca Mazzuchelli, Michael Medinger, Alexandar Tzankov
Clinical benefit of glasdegib plus low-dose cytarabine in patients with de novo and secondary acute myeloid leukemia: long-term analysis of a phase II randomized trial
Michael Heuser, B. Douglas Smith, Walter Fiedler, Mikkael A. Sekeres, Pau Montesinos, Brian Leber, Akil Merchant, Cristina Papayannidis, José A. Pérez-Simón, Caroline J. Hoang, Thomas O’Brien, Weidong Wendy Ma, Mirjana Zeremski, Ashleigh O’Connell, Geoffrey Chan, Jorge E. Cortes
Glasdegib in combination with low-dose Cytarabine for the outpatient treatment of relapsed or refractory acute myeloid leukemia in unfit patients
Andrius Zucenka, Kazimieras Maneikis, Birute Pugaciute, Ugne Ringeleviciute, Austeja Dapkeviciute, Linas Davainis, Guoda Daukelaite, Paulina Burzdikaite, Vytautas Staras, Laimonas Griskevicius
Both the subtypes of KIT mutation and minimal residual disease are associated with prognosis in core binding factor acute myeloid leukemia: a retrospective clinical cohort study in single center
Wenbing Duan, Xiaohong Liu, Xiaosu Zhao, Jinsong Jia, Jing Wang, Lizhong Gong, Qian Jiang, Ting Zhao, Yu Wang, Xiaohui Zhang, Lanping Xu, Hongxia Shi, Yingjun Chang, Kaiyan Liu, Xiaojun Huang, Yazhen Qin, Hao Jiang
Real-life comparison of nilotinib versus dasatinib as second-line therapy in chronic phase chronic myeloid leukemia patients
Emilia Scalzulli, Giovanni Caocci, Fabio Efficace, Lorenzo Rizzo, Gioia Colafigli, Alessio Di Prima, Sara Pepe, Danilo Alunni Fegatelli, Ida Carmosino, Daniela Diverio, Roberto Latagliata, Giorgio La Nasa, Maurizio Martelli, Robin Foà, Massimo Breccia
Clinical Impact of Extranodal Metabolic Tumor Volume in 240 Diffuse Large B cell Lymphoma Patients with Extranodal Involvement
Moo-Kon Song, Joo-Seop Chung, Sung-Nam Lim, Won-Sik Lee, Sang-Min Lee, Seong-Jang Kim, Hye-Kyung Shim, Seok-Mo Lee
Age and comorbidity are determining factors in the overall and relative survival of patients with follicular lymphoma
Pablo Mozas, Andrea Rivero, Alfredo Rivas-Delgado, Ferran Nadeu, Juan Gonzalo Correa, Carlos Castillo, Alex Bataller, Tycho Baumann, Eva Giné, Julio Delgado, Neus Villamor, Elías Campo, Laura Magnano, Armando López-Guillermo
Whole-body low-dose computed tomography (WBLDCT) in staging and re-staging of multiple myeloma
Davide Ippolito, Teresa Giandola, Cesare Maino, Anna Pecorelli, Maria Ragusi, Marco Porta, Davide Gandola, Cammillo Talei Franzesi, Sandro Sironi
The combination of C-Myc rearrangement and 1q21 gain is associated with poor prognosis in multiple myeloma
Yuanyuan Jin, Xiaochen Yu, Jianhua Du, Hui Li, Wenjiao Tang, Congwei Jia, Yunyan Zan, Miao Chen, Yanbin Zhang, Minhong Yu, Weiqi Rong, Daobin Zhou, Junling Zhuang
Renal failure among multiple myeloma patients utilizing carfilzomib and associated factors in the “real world”
Hira S. Mian, Mark A. Fiala, Larysa Sanchez, Ravi Vij, Tanya M. Wildes
Minimal residual disease monitoring and preemptive immunotherapies for frequent 11q23 rearranged acute leukemia after allogeneic hematopoietic stem cell transplantation
Jing Liu, Xiao-Hui Zhang, Lan-Ping Xu, Yu Wang, Chen-Hua Yan, Huan Chen, Yu-Hong Chen, Wei Han, Feng-Rong Wang, Jing-Zhi Wang, Yi-Fei Cheng, Ya-Zhen Qin, Kai-Yan Liu, Xiao-Jun Huang, Xiao-Su Zhao, Xiao-Dong Mo
Prospective analysis of BKV hemorrhagic cystitis in children and adolescents undergoing hematopoietic cell transplantation
Małgorzata Salamonowicz-Bodzioch, Jowita Frączkiewicz, Krzysztof Czyżewski, Olga Zając-Spychała, Ewa Gorczyńska, Anna Panasiuk, Marek Ussowicz, Krzysztof Kałwak, Zofia Szmit, Grażyna Wróbel, Bernarda Kazanowska, Alicja Chybicka, Bogna Ukielska-Hoffmann, Danuta Wendycz-Domalewska, Mariusz Wysocki, Magdalena Dziedzic, Jacek Wachowiak, Agnieszka Zaucha-Prażmo, Jerzy Kowalczyk, Jolanta Goździk, Jan Styczyński
Early administration of cyclosporine may reduce the incidence of cytokine release syndrome after HLA-haploidentical hematopoietic stem-cell transplantation with post-transplant cyclophosphamide
Naoki Kurita, Tatsuhiro Sakamoto, Takayasu Kato, Manabu Kusakabe, Yasuhisa Yokoyama, Hidekazu Nishikii, Mamiko Sakata-Yanagimoto, Naoshi Obara, Yuichi Hasegawa, Shigeru Chiba
Umbilical cord blood transplantation can overcome the poor prognosis of KMT2A-MLLT3 acute myeloid leukemia and can lead to good GVHD-free/relapse-free survival
Juan Tong, Lei Zhang, Huilan Liu, Xiucai Xu, Changcheng Zheng, Wen Yao, Xiaoyu Zhu, Baolin Tang, Xiang Wan, Kaidi Song, Xuhan Zhang, Guangyu Sun, Zimin Sun
Moderate-severe grade of chronic graft versus host disease and younger age (less than 45 years old) are risk factors for avascular necrosis in adult patients undergoing allogeneic hematopoietic cell transplantation
Arjun Datt Law, Sita Bhella, Ivan Pasic, Wilson Lam, Fotios V. Michelis, Armin Gerbitz, Auro Viswabandya, Rajat Kumar, Jeffrey H. Lipton, Jonas Mattsson, Dennis Dong Hwan Kim
High lymphocyte counts before antithymocyte globulin administration predict acute graft-versus-host disease
Souichi Shiratori, Hiroyuki Ohigashi, Takahide Ara, Atsushi Yasumoto, Hideki Goto, Masao Nakagawa, Junichi Sugita, Masahiro Onozawa, Kaoru Kahata, Tomoyuki Endo, Daigo Hashimoto, Takanori Teshima
Effective treatment with imatinib for acute B-lymphoblastic leukaemia with EBF1-PDGFRB fusion
Mirei Horiuchi, Masahiro Yoshida, Kai Yamasaki, Ryoko Sakagami, Takane Aoyama, Naoko Tatsumi, Minako Tsutsumi, Yosuke Nakaya, Hoyuri Fuseya, Takuro Yoshimura, Yoshiki Hayashi, Takafumi Nakao, Takahisa Yamane
Venetoclax-induced panniculitis in an acute myeloid leukemia patient
Po-Wei Liao, Ren Ching Wang, Tsung-Chih Chen, Chieh-Lin Jerry Teng
Low-density lipoprotein (LDL) and the risk of thrombotic events in essential thrombocythemia and polycythemia vera
Ivan Krečak, Hrvoje Holik, Božena Coha, Martina Morić Perić, Ivan Zekanović, Marija Valovičić Krečak, Velka Gverić-Krečak, Marko Lucijanić
Clonal derivation of sequential seminoma and acute megakaryoblastic leukaemia
Karen H. K. Tang, Alvin H. W. Ip, Yok-Lam Kwong
A retrospective analysis on arteritis after administration of granulocyte colony-stimulating factor
Ken Sasaki, Kensuke Matsuda, Masashi Miyauchi, Akira Honda, Arika Shimura, Yosuke Masamoto, Mineo Kurokawa
Fatal splenic rupture after discontinuing treatment by ibrutinib and venetoclax in relapse/refractory mantle cell lymphoma
Louise Roulin, Corinne Haioun, François Lemonnier
Does the order of busulfan and cyclophosphamide affect allogeneic stem cell transplantation related liver toxicity?
Claire Seydoux, Jakob R. Passweg, Michael Medinger
Daratumumab for refractory warm autoimmune hemolytic anemia
Ankur Jain, D. K. Gupta
dsDNA from extracellular vesicles (EVs) in adult AML
Simona Bernardi, C. Zanaglio, M. Farina, N. Polverelli, M. Malagola, D. Russo
Rosette-like formation in multiple myeloma
Masanori Aoki, Naoki Takahashi, Yoshitada Taji, Masanori Yasuda, Norio Asou, Yasuhiro Ebihara